Literature DB >> 9576868

Nitroarginine and tetrahydrobiopterin binding to the haem domain of neuronal nitric oxide synthase using a scintillation proximity assay.

W K Alderton1, A Boyhan, P N Lowe.   

Abstract

Nitric oxide synthases (NOS) have a bidomain structure comprised of an N-terminal oxygenase domain and a C-terminal reductase domain. The oxygenase domain binds haem, (6R)-5,6,7,8-tetrahydro-l-biopterin (tetrahydrobiopterin) and arginine, is the site where nitric oxide synthesis takes place and contains determinants for dimeric interactions. A novel scintillation proximity assay has been established for equilibrium and kinetic measurements of substrate, inhibitor and cofactor binding to a recombinant N-terminal haem-binding domain of rat neuronal NOS (nNOS). Apparent Kd values for nNOS haem-domain-binding of arginine and Nomega-nitro-L-arginine (nitroarginine) were measured as 1.6 microM and 25 nM respectively. The kinetics of [3H]nitroarginine binding and dissociation yielded an association rate constant of 1.3x10(4) s-1.M-1 and a dissociation rate constant of 1.2x10(-4) s-1. These values are comparable to literature values obtained for full-length nNOS, suggesting that many characteristics of the arginine binding site of NOS are conserved in the haem-binding domain. Additionally, apparent Kd values were compared and were found to be similar for the inhibitors, L-NG-monomethylarginine, S-ethylisothiourea, N-iminoethyl-L-ornithine, imidazole, 7-nitroindazole and 1400W (N-[3-(aminomethyl) benzyl] acetamidine). [3H]Tetrahydrobiopterin bound to the nNOS haem domain with an apparent Kd of 20 nM. Binding was inhibited by 7-nitroindazole and stimulated by S-ethylisothiourea. The kinetics of interaction with tetrahydrobiopterin were complex, showing a triphasic binding process and a single off rate. An alternating catalytic site mechanism for NOS is proposed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576868      PMCID: PMC1219468          DOI: 10.1042/bj3320195

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Mutagenesis of acidic residues in the oxygenase domain of inducible nitric-oxide synthase identifies a glutamate involved in arginine binding.

Authors:  R Gachhui; D K Ghosh; C Wu; J Parkinson; B R Crane; D J Stuehr
Journal:  Biochemistry       Date:  1997-04-29       Impact factor: 3.162

2.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.

Authors:  D S Bredt; P M Hwang; C E Glatt; C Lowenstein; R R Reed; S H Snyder
Journal:  Nature       Date:  1991-06-27       Impact factor: 49.962

3.  1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo.

Authors:  E P Garvey; J A Oplinger; E S Furfine; R J Kiff; F Laszlo; B J Whittle; R G Knowles
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

4.  Cysteine-200 of human inducible nitric oxide synthase is essential for dimerization of haem domains and for binding of haem, nitroarginine and tetrahydrobiopterin.

Authors:  R R Cubberley; W K Alderton; A Boyhan; I G Charles; P N Lowe; R W Old
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

Review 5.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

6.  Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyl transferase.

Authors:  D S Duch; S W Bowers; C A Nichol
Journal:  Biochem Pharmacol       Date:  1978-05-15       Impact factor: 5.858

7.  Tetrahydrobiopterin-free neuronal nitric oxide synthase: evidence for two identical highly anticooperative pteridine binding sites.

Authors:  A C Gorren; B M List; A Schrammel; E Pitters; B Hemmens; E R Werner; K Schmidt; B Mayer
Journal:  Biochemistry       Date:  1996-12-24       Impact factor: 3.162

8.  Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms.

Authors:  R C Venema; H Ju; R Zou; J W Ryan; V J Venema
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

9.  Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine.

Authors:  E S Furfine; M F Harmon; J E Paith; E P Garvey
Journal:  Biochemistry       Date:  1993-08-24       Impact factor: 3.162

10.  The structure of bovine F1-ATPase complexed with the peptide antibiotic efrapeptin.

Authors:  J P Abrahams; S K Buchanan; M J Van Raaij; I M Fearnley; A G Leslie; J E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  5 in total

1.  Nitric oxide-induced autoinhibition of neuronal nitric oxide synthase in the presence of the autoxidation-resistant pteridine 5-methyltetrahydrobiopterin.

Authors:  A C Gorren; A Schrammel; C Riethmüller; K Schmidt; D Koesling; E R Werner; B Mayer
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

Review 2.  Nitric oxide synthases: structure, function and inhibition.

Authors:  W K Alderton; C E Cooper; R G Knowles
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

3.  Allosteric regulation of neuronal nitric oxide synthase by tetrahydrobiopterin and suppression of auto-damaging superoxide.

Authors:  P Kotsonis; L G Fröhlich; Z V Shutenko; R Horejsi; W Pfleiderer; H H Schmidt
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

4.  Cobalamin in inflammation III - glutathionylcobalamin and methylcobalamin/adenosylcobalamin coenzymes: the sword in the stone? How cobalamin may directly regulate the nitric oxide synthases.

Authors:  Carmen Wheatley
Journal:  J Nutr Environ Med       Date:  2008-01-10

5.  Interaction between neuronal nitric-oxide synthase and tetrahydrobiopterin revisited: studies on the nature and mechanism of tight pterin binding.

Authors:  Christian L Heine; Bernd Kolesnik; Renate Schmidt; Ernst R Werner; Bernd Mayer; Antonius C F Gorren
Journal:  Biochemistry       Date:  2014-02-17       Impact factor: 3.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.